GILD vs OFLX · P/E 18, rev $7.80B vs P/E 23, rev $47.1M
Gilead Sciences Inc (GILD) versus Omega Flex Inc (OFLX) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Omega Flex Inc (OFLX) is a specialty industrial machinery company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported OFLX revenue for 2026-06-30 was $47.1M. Net income was $4.8M. OFLX currently screens at market cap $304.0M and trailing P/E 22.6.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. OFLX currently screens at market cap $304.0M and trailing P/E 22.6.
Not investment advice. Open the GILD and OFLX stock pages for the full models.
Not investment advice.